.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
The SOUND randomized clinical trial asked whether sentinel lymph-node biopsy could be omitted altogether in women with small, clinically node-negative breast cancers when preoperative axillary ultrasonography showed no suspicious nodes. The study found that omission of axillary surgery was associated with excellent distant disease-free outcomes and did not compromise the broader treatment strategy in appropriately selected patients. This is an important step in surgical de-escalation because even sentinel-node biopsy is an invasive procedure with potential morbidity, although much less than full axillary dissection. The practical lesson for breast surgeons is that staging procedures should be proportional to the clinical question they need to answer. In carefully selected patients receiving modern breast cancer therapy, imaging and tumor characteristics may allow the axilla to be left untouched. The findings do not apply to every patient with breast cancer; tumor size, nodal imaging, biology and planned systemic or radiation treatment remain central to selection. SOUND therefore supports individualized, risk-adapted surgical planning.
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
The SOUND randomized clinical trial asked whether sentinel lymph-node biopsy could be omitted altogether in women with small, clinically node-negative breast cancers when preoperative axillary ultrasonography showed no suspicious nodes. The study found that omission of axillary surgery was associated with excellent distant disease-free outcomes and did not compromise the broader treatment strategy in appropriately selected patients. This is an important step in surgical de-escalation because even sentinel-node biopsy is an invasive procedure with potential morbidity, although much less than full axillary dissection. The practical lesson for breast surgeons is that staging procedures should be proportional to the clinical question they need to answer. In carefully selected patients receiving modern breast cancer therapy, imaging and tumor characteristics may allow the axilla to be left untouched. The findings do not apply to every patient with breast cancer; tumor size, nodal imaging, biology and planned systemic or radiation treatment remain central to selection. SOUND therefore supports individualized, risk-adapted surgical planning.
Yesterday
The phase 3 ACACIA-HCM trial reveals that aficamten improves cardiac structure, diastolic relaxation, functional capacity, and symptom burden in symptomatic nonobstructive hypertrophic cardiomyopathy, marking a major milestone in targeted myosin inhibition.
6 days back
A clinical study shows that automated breast ultrasound paired with artificial intelligence accurately classifies BIRADS 3-4 lesions, reaching 95% sensitivity and 79% specificity. This diagnostic advance promises to reduce unnecessary core needle biopsies and refine clinical workflows in breast imaging.
3 weeks back
Researchers have engineered freestanding hierarchical-porous BCZT thin films that resist cracking and enhance ultrasonic energy harvesting in soft tissue. Achieving high piezoelectric output and acoustic matching, this lead-free material offers transformative potential for implantable bioelectronics.
6 days back
A novel pathology-adaptive surface engineering strategy uses functionalized plasma polymer coatings to selectively modulate AGE adsorption, reducing oxidative stress and restoring bone formation in diabetic and aging microenvironments.
3 weeks back
A breakthrough study identifies the Klotho/PKCα/CUX1/SPARC/TGFβ-RII axis as a critical driver of podocyte mitochondrial injury and ferroptosis in diabetic kidney disease, unveiling promising molecular targets to halt renal disease progression.
6 days back
